Results 131 to 140 of about 11,119 (206)

Radiology‐Dermatology Diagnostic Variation in Skin and Soft Tissue Infections: A Cohort Analysis

International Journal of Dermatology, EarlyView.
Varshita Chirumamilla, Matthew Gallardo, Abraham M. Korman, Kristopher Fisher, Benjamin H. Kaffenberger, Rachel M. Kirven   +5 more
wiley   +1 more source

Genomic and proteomic insights into hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A dual pathogenic model of HS involving both epithelial dysfunction and systemic inflammation is supported. The HLA‐DRA association hints at autoimmune overlap, but the proteomic signature which is dominated by innate immune mediators favours an autoinflammatory classification, which may guide future therapeutic strategies and patient stratification ...
Maria Argyropoulou, Emmanouil Stylianakis, Isis Ricaño‐Ponce, Nick Keur, Theodora Kanni, Dimitra Stergianou, Mihai G. Netea, Vinod Kumar, Evangelos J. Giamarellos‐Bourboulis   +8 more
wiley   +1 more source

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?

Clinical and Experimental Gastroenterology, 2020
Rodrigo Fedatto Beraldo,1 Mariana Barros Marcondes,1 Julio Pinheiro Baima,1 Jaqueline Ribeiro Barros,1 Madhoor Ramdeen,2 Rogerio Saad-Hossne,3 Ligia Yukie Sassaki1 1Department of Internal Medicine, São Paulo State University (Unesp), Medical ...
Beraldo RF, Marcondes MB, Baima JP, Barros JR, Ramdeen M, Saad-Hossne R, Sassaki LY   +6 more
doaj  

Assessing the Impact of Financial Toxicity on Quality of Life in Patients With Hidradenitis Suppurativa: A Cross‐Sectional Survey Study

International Journal of Dermatology, EarlyView.
Divya M. Shan, Aaron D. Smith, Catherine E. Lyons, Hope Winfield, Samuel Soon, Rasha Alsaadawi, R. Hal Flowers   +6 more
wiley   +1 more source

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

Journal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta, Julia Steriopoulos, Vasiliki Economopoulos, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

Prescribing Patterns in Pediatric Hidradenitis Suppurativa

Pediatric Dermatology, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin condition increasingly diagnosed in pediatric populations; however, data on treatment practices in this group remains limited. In this retrospective study of 163 patients diagnosed with HS ≤ 18 years of age, we found that treatment patterns varied significantly by disease severity.
Hannah Neimy, Courtney L. Walker, Lara Wine Lee, Colleen H. Cotton   +3 more
wiley   +1 more source

A protocol for a randomized controlled trial for assessing the efficacy and safety of tratments in hidradenitis [PDF]

, 2016
Δαλαμπούρα, Δέσποινα
core   +1 more source

Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Ab Peptide Seeds [PDF]

, 2016
Recently it was proposed that the familial Alzheimer’s disease (FAD) causing presenilin (PSEN) mutations PSEN1-L435F and PSEN1-C410Y do not support the generation of Aβ-peptides from the amyloid precursor protein (APP).
Chavez-Gutierrez, L, De Strooper, B, Saido, TC, Saito, T, Veugelen, S   +4 more
core  

Racial Differences in Dermatologic Treatment for Adolescents With PCOS‐Related Acne Vulgaris

Pediatric Dermatology, EarlyView.
ABSTRACT Background/Objectives Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, with acne frequently appearing during adolescence. Racial and ethnic disparities in PCOS phenotype and adult acne treatment are well documented, yet differences in acne management among adolescents with PCOS remain unclear.
Samantha Garcia, Brandi Kenner‐Bell
wiley   +1 more source

Setmelanotide in Bardet‐Biedl Syndrome: A Case Report

Pediatric Dermatology, EarlyView.
ABSTRACT Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication.
Shelby Smith, Eric Sanfilippo, Lara Wine Lee   +2 more
wiley   +1 more source